This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter          

Search results for "" (5753)

Green light for full budesonide approval as study shows efficacy in primary IgA nephropathy
EU approval granted for nivolumab as adjuvant treatment for resected stage IIB or IIC melanoma
Atogepant approved in the EU for migraine prophylaxis
Patient safety alert issued in the UK over risk of death relating to medical beds
MHRA approves bimekizumab for psoriatic arthritis and axial spondyloarthritis
Mitazalimab gains EMA orphan drug designation for pancreatic cancer
ESC: Calls for urgent action as economic burden of CVD in Europe exceeds entire EU budget
Higher cardiorespiratory fitness in young men linked to lower risk of cancer
ESC: Intravenous iron reduces hospitalisations for iron-deficient heart failure patients
Recreational drug use prevalent among intensive cardiac care unit admissions, study finds
EU-funded project to reduce cardiac damage from breast cancer therapy set to launch clinical trial
ESC: Increased sedentary time in childhood leads to higher left ventricular mass in young adulthood
Clopidogrel ineffective for myocardial infarction prevention in majority of British south Asians
ESC: Survivors of MI discontinuing aspirin at higher risk of subsequent adverse cardiac events
ESC: Recognising myocardial infarction signs and symptoms improves survival
NICE recommends birch bark extract for epidermolysis bullosa-induced wounds
Artificial intelligence technologies could speed up contouring in radiotherapy
Talquetamab gains EC approval for use in relapsed/refractory multiple myeloma
Higher self-reported pain 12 months post-MI associated with increased mortality risk
Anti-IL17 peptide shows high clinical efficacy for immune-related inflammatory diseases
Assessing the recent turning point in vitiligo treatment
Discovery of Achilles heel for chronic myeloid leukaemia fuels treatment hope
Do JAK inhibitors increase the risk of MACE in atopic eczema?
MHRA and NICE approve two-component therapy for late-onset Pompe disease
Higher CVD risk in patients with obstructive sleep apnoea taking beta-blockers
Air pollution linked to increased use of psychiatric services in people with dementia
Has the mechanism for the CV benefits of light-to-moderate alcohol consumption been found?